Evidence map›Paper›PMID 36199108›Full record

ArticleBMC biology2022

A novel nuclear receptor subfamily enlightens the origin of heterodimerization.

Brice Beinsteiner, Gabriel V Markov, Maxime Bourguet, Alastair G McEwen, Stéphane Erb, Abdul Kareem Mohideen Patel, Fatima Z El Khaloufi El Khaddar, Claire Lecroisey, Guillaume Holzer, Karim Essabri and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. First characterization of the nuclear receptor superfamily in the Mediterranean musselPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  5. Article
  6. Article
  7. Structural insights into the HNF4 biology.Frontiers in endocrinology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 4 countries.

Brice Beinsteiner *IGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.
Gabriel V Markov *Sorbonne Université, CNRS, UMR 8227, Integrative Biology of Marine Models, (LBI2M, UMR8227), Station Biologique de Roscoff (SBR), 29680, Roscoff, France.
Maxime BourguetLaboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67000, Strasbourg, France.
Alastair G McEwenIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.
Stéphane ErbLaboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67000, Strasbourg, France.
Abdul Kareem Mohideen PatelIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.
Fatima Z El Khaloufi El KhaddarIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.
Claire LecroiseyEcole Normale Supérieure de Lyon, Université de Lyon, Institut de Génomique Fonctionnelle de Lyon, UMR 5242 CNRS, Molecular Zoology Team, 46 allée d'Italie, 69364, Lyon, Cedex 07, France.
Guillaume HolzerEcole Normale Supérieure de Lyon, Université de Lyon, Institut de Génomique Fonctionnelle de Lyon, UMR 5242 CNRS, Molecular Zoology Team, 46 allée d'Italie, 69364, Lyon, Cedex 07, France.
Karim EssabriIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.
Isabelle HazemannIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.
Ali HamicheIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.
Sarah CianféraniLaboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67000, Strasbourg, France.
Dino MorasIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.
Vincent LaudetMarine Eco-Evo-Devo Unit, Okinawa Institute of Science and Technology, 1919-1 Tancha, Onna-son, Okinawa, 904-0495, Japan. vincent.laudet@oist.jp.
Isabelle M L BillasIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France. billas@igbmc.fr.ORCID 0000-0003-2323-4208
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FROkinawa Institute of Science and Technology Graduate University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNuclear receptors are transcription factors of central importance in human biology and associated diseases. Much of the knowledge related to their major functions, such as ligand and DNA binding or dimerization, derives from functional studies undertaken in classical model animals. It has become evident, however, that a deeper understanding of these molecular functions requires uncovering how these characteristics originated and diversified during evolution, by looking at more species. In particular, the comprehension of how dimerization evolved from ancestral homodimers to a more sophisticated state of heterodimers has been missing, due to a too narrow phylogenetic sampling. Here, we experimentally and phylogenetically define the evolutionary trajectory of nuclear receptor dimerization by analyzing a novel NR7 subgroup, present in various metazoan groups, including cnidarians, annelids, mollusks, sea urchins, and amphioxus, but lost in vertebrates, arthropods, and nematodes.

resultsWe focused on NR7 of the cephalochordate amphioxus B. lanceolatum. We present a complementary set of functional, structural, and evolutionary analyses that establish that NR7 lies at a pivotal point in the evolutionary trajectory from homodimerizing to heterodimerizing nuclear receptors. The crystal structure of the NR7 ligand-binding domain suggests that the isolated domain is not capable of dimerizing with the ubiquitous dimerization partner RXR. In contrast, the full-length NR7 dimerizes with RXR in a DNA-dependent manner and acts as a constitutively active receptor. The phylogenetic and sequence analyses position NR7 at a pivotal point, just between the basal class I nuclear receptors that form monomers or homodimers on DNA and the derived class II nuclear receptors that exhibit the classical DNA-independent RXR heterodimers.

conclusionsOur data suggest that NR7 represents the "missing link" in the transition between class I and class II nuclear receptors and that the DNA independency of heterodimer formation is a feature that was acquired during evolution. Our studies define a novel paradigm of nuclear receptor dimerization that evolved from DNA-dependent to DNA-independent requirements. This new concept emphasizes the importance of DNA in the dimerization of nuclear receptors, such as the glucocorticoid receptor and other members of this pharmacologically important oxosteroid receptor subfamily. Our studies further underline the importance of studying emerging model organisms for supporting cutting-edge research.

Indexed as

Receptors, GlucocorticoidReceptors, Retinoic AcidAnimalsDimerizationDNAHumansKetosteroidsLigandsPhylogenyReceptors, Cytoplasmic and NuclearRetinoid X ReceptorsDNAKetosteroidsLigandsReceptors, Cytoplasmic and NuclearReceptors, GlucocorticoidReceptors, Retinoic AcidRetinoid X ReceptorsAmphioxusNon-model animalsNR7; Crystal structure; Native mass spectrometryNuclear receptor dimerizationNuclear receptor phylogeny

Identifiers

PMID36199108
PMCPMC9535869
OpenAlexW4302027612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.